Related Experiment Video
Updated: Jan 22, 2026
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Pharmacologic Management of Neonatal Abstinence Syndrome Using a Protocol
Brandi L Gibson1, Kristi Coe, Wanda Bradshaw
1Duke University School of Nursing, Durham, North Carolina.
Insights
Strict weaning protocols, not specific medications like morphine or methadone, significantly improve outcomes for Neonatal Abstinence Syndrome (NAS). Adhering to rigid guidelines shortens hospital stays and reduces costs for infants born with opioid withdrawal.
Area of Science:
- Neonatal care
- Pharmacology
- Public Health
Background:
- The opioid epidemic significantly impacts vulnerable populations, leading to a rise in Neonatal Abstinence Syndrome (NAS).
- Increased neonatal intensive care unit admissions and healthcare costs are associated with NAS.
- Existing research on the most effective NAS treatment presents mixed results.
Purpose of the Study:
- To compare the effectiveness of morphine and methadone in treating NAS.
- To evaluate treatment efficacy within a standardized protocol framework.
Main Methods:
- A comprehensive literature search was conducted using PubMed and CINAHL.
- Ten quantitative studies were analyzed to identify potential practice changes.
Main Results:
- Standardized, stringent weaning protocols are more beneficial than the choice of pharmacologic agent.
- Studies indicate shorter weaning times and hospital stays for infants managed with rigid guidelines.
Conclusions:
- Rigid guidelines for NAS management improve clinical outcomes, reduce hospital length, and lower healthcare costs.
- Further research is needed to develop optimal protocol-based weaning regimens for NAS.
- Healthcare institutions should reassess current NAS protocols based on evidence supporting stringent guidelines.
Background:
The opioid epidemic in the United States has reached unprecedented proportions with far-reaching impacts on the most vulnerable population. The number of neonates born addicted to opioids has grown exponentially over the last several decades, leading to increased neonatal intensive care unit admissions and rising healthcare costs. Recent studies have yielded mixed results regarding which medication is most effective at relieving the symptoms of opioid withdrawal and reducing the weaning timeframe for babies with neonatal abstinence syndrome (NAS).
Purpose:
To explore and compare the effectiveness of morphine versus methadone in the treatment for NAS using a standardized protocol.
Method:
A literature search of PubMed and CINAHL was performed. The search yielded 10 quantitative studies that were analyzed for potential practice changes.
Conclusion:
Based on current literature, following a standardized, stringent weaning protocol is more beneficial than the pharmacologic agent used. Studies reveal shorter weaning times and hospital stays in almost every group that followed rigid guidelines.
Implication For Research:
Although current studies are promising for the desired outcome, more research is needed to develop appropriate protocol-based weaning regimens for management of NAS.
Implication For Practice:
As the occurrence of NAS continues to rise, its management must vigorously meet the challenges of the diagnosis. Institutions should reevaluate their current protocols based on reassuring data showing that stringent guidelines using morphine or methadone can improve clinical outcomes, reduce hospital length, and lower healthcare costs.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:26Acute Coronary Syndrome V: Nursing Management
01:26Nephrotic Syndrome II : Assessment and Medical Management
01:24Nephrotic Syndrome III : Nursing Management
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management